Skip to search formSkip to main contentSkip to account menu

saxagliptin 5 MG Oral Tablet [Onglyza]

Known as: Onglyza (as saxagliptin hydrochloride 5.58 MG) 5 MG Oral Tablet, onglyza 5 MG Oral Tablet, saxagliptin hydrochloride 5 mg ORAL TABLET, FILM COATED [ONGLYZA] 
National Institutes of Health

Related topics

Related topics

8 relations
Croscarmellose SodiumLactose MonohydrateMagnesium stearateOnglyza

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Arthralgies et arthrites d’origine médicamenteuses, rares ou émergentes
2015
2015
Of the Big Daddy, the Underdog, the Mother Hen, and the Scapegoats: Balancing Pharmaceutical Innovation and Access to Healthcare in the Enforcement of Compulsory Patent Licensing in India, its…
2014
2014
Saxagliptin: a guide to its use in type 2 diabetes mellitus
Oral saxagliptin (Onglyza®), a potent, selective dipeptidyl pepitase-4 inhibitor, is a useful option to improve glycaemic control… 
2012
2012
Effect of saxagliptin on the pharmacokinetics of the active components of Ortho‐Cyclen®, a combined oral contraceptive containing ethinyl estradiol and norgestimate, in healthy women
Saxagliptin (Onglyza™) is a dipeptidyl peptidase‐4 (DPP4) inhibitor for treating type 2 diabetes mellitus. This open‐label… 
2010
2010
La saxagliptine (Onglyza®) - un nouvel inhibiteur de la DPP-4 pour le traitement oral du diabète de type 2
• L'enzyme DPP-4 degrade physiologiquement les incretines GLP-1 et GIP. • La saxagliptine (Onglyza ® ) est un inhibiteur oral de… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)